CompletedPhase 3NCT00049803
Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
Studying Narcolepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Orphan Medical
- Principal Investigator
- William Houghton, MDOrphan Medical
- Intervention
- sodium oxybate(drug)
- Enrollment
- 200 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2000 – 2004
Study locations (30)
- Sleep Disorders Center of Alabama, Inc., Birmingham, Alabama, United States
- Pacific Sleep Medicine Services, La Jolla, California, United States
- Stanford Sleep Disorders Clinic, Stanford, California, United States
- St. Petersburg Sleep Disorders Center, St. Petersburg, Florida, United States
- Sleep Disorders Center of Georgia, Atlanta, Georgia, United States
- Sleep Disorders Center--Division of Neurology, Evanston, Illinois, United States
- Peoria Pulmonary Associates, Ltd., Peoria, Illinois, United States
- The Center for Sleep and Wake Disorders/Midwest Neurology, Danville, Indiana, United States
- Fort Wayne Neurological Center, Fort Wayne, Indiana, United States
- Chest Medicine Associates DBA/Sleep Medicine Specialists, Louisville, Kentucky, United States
- LSU Health Science Center, Shreveport, Louisiana, United States
- Center for Sleep and Wake Disorders, Chevy Chase, Maryland, United States
- Center for Sleep Diagnostics, Newton, Massachusetts, United States
- Department of Neurology, Worcester, Massachusetts, United States
- Washington University -- Sleep Medicine Center, St Louis, Missouri, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00049803 on ClinicalTrials.govOther trials for Narcolepsy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07365566Pain Assessment in Patients With Idiopathic REM Sleep Behaviour DisorderUniversity Hospital, Toulouse
- RECRUITINGPHASE3NCT07363720A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyTakeda
- RECRUITINGNCT07299097Epidemiology of Narcolepsy Type 1 and Type 2 in SpainTakeda
- RECRUITINGPHASE2NCT06809803Extended-release Sodium Oxybate in ChildrenStanford University
- RECRUITINGPHASE1NCT06961266A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1Jazz Pharmaceuticals
- RECRUITINGPHASE2NCT06952699A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)Takeda
- RECRUITINGNCT06292598Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control PopulationCentre Hospitalier Universitaire de Nīmes
- RECRUITINGNANCT06797284The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake DisordersSecond Affiliated Hospital of Soochow University